Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat ...
Entropy Neurodynamics has secured an Australian patent covering proprietary crystalline forms of psilocin, strengthening its ...
Tryptamine Therapeutics ( (AU:ENP)) has issued an update. Entropy Neurodynamics Limited has successfully completed the first patient dosing in its clinical trial for treating Binge Eating Disorder ...
Hosted on MSN
Entropy Neurodynamics secures $847,186 R&D tax refund to advance psychedelic therapy trials
Tryptamine Therapeutics ( (AU:ENP)) has shared an update. Entropy Neurodynamics has received an $847,186 cash refund under Australia’s R&D Tax Incentive for its FY24 eligible research and development ...
11d
Entropy’s IV-infused psilocin TRP-8803 delivers 50% remission in treatment-resistant BED patients
Entropy Neurodynamics has released positive topline safety and efficacy results from Cohort 1 of a Phase II trial of its lead ...
As of July 16 at 4:00:00 PM EDT. Market Open.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results